LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply
AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.
-
Filed today
-
Companies tracked
NSE & BSE
Listed on
👋Welcome back, there - you're tracking 0 companies
🔔Sign in free to track companies and get alerts the moment they file
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors
Latest Filings -
📋 Filing Types Available on ForgeUp Filings
Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
The company reported a financial loss this quarter, with revenues at Rs. 9,417.85 lakhs.
🤖 AI Summary
Zim Laboratories Ltd. reported a consolidated net loss after tax of Rs. (401.70) lakhs for the quarter ended 30 June 2026.
Consolidated revenue from operations for Q1 FY27 was Rs. 9,417.85 lakhs.
Total consolidated expenses for the quarter reached Rs. 10,074.38 lakhs.
Basic and Diluted Earnings Per Share (EPS) for the quarter stood at Rs. (0.75).
The Board approved the unaudited standalone and consolidated financial results on 06 August 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Consolidated Revenue from operations (Q1 FY27)
9,417.85 Rs. in lakhs
31.24%
Consolidated Net Profit / (loss) after tax (Q1 FY27)
(401.70) Rs. in lakhs
Not comparable — limited prior period data.
Consolidated Basic EPS (Q1 FY27)
(0.75) Rs.
Not comparable — limited prior period data.
Total Consolidated Expenses (Q1 FY27)
10,074.38 Rs. in lakhs
33.15%
🏢 How This Affects the Company
📈
Business Impact
The decline in revenue from operations from Rs. 10,527.34 lakhs in Q4 FY26 to Rs. 9,417.85 lakhs in Q1 FY27 indicates a contraction in sales during the quarter.
💰
Financial Impact
The company recorded a consolidated net loss after tax of Rs. (401.70) lakhs, moving from a profit of Rs. 373.99 lakhs in the preceding quarter, directly affecting profitability and retained earnings.
⚙️
Operational Impact
Not directly stated in the financial results. The increase in employee benefits expense to Rs. 1,918.37 lakhs from Rs. 1,739.15 lakhs suggests a potential change in workforce-related costs.
⚠️
Risk Impact
The shift to a net loss and increased expenses relative to revenue could signal short-term financial pressure, requiring close monitoring of cost management and revenue generation strategies.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are impacted by the reported net loss of Rs. (401.70) lakhs and the negative Basic and Diluted EPS of Rs. (0.75), which reflects on the company's profitability for the quarter.
🔍
Management Signal
The management's approval and disclosure of these results indicate adherence to regulatory requirements and transparency regarding the company's Q1 FY27 financial performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q2 FY27 financial results — monitor revenue and profitability trends.
Management commentary during next earnings call for operational insights.
Any future announcements regarding cost control measures or revenue growth strategies.
MEDIUM RISKThe company reported a net loss for the quarter and a decline in revenue from previous quarter.
💡 Investor Takeaway
Zim Laboratories Ltd. reported a consolidated net loss after tax of Rs. (401.70) lakhs for the quarter ended 30 June 2026, a decline from Rs. 373.99 lakhs profit in the prior quarter. Revenue from operations for the quarter stood at Rs. 9,417.85 lakhs, lower than the Rs. 10,527.34 lakhs in Q4 FY26.
⚖️ Strengths & Concerns
⚠️ Concerns
Net Profit after tax shifted to a loss of Rs. (401.70) lakhs in Q1 FY27 from a profit of Rs. 373.99 lakhs in Q4 FY26.
Revenue from operations decreased to Rs. 9,417.85 lakhs in Q1 FY27 from Rs. 10,527.34 lakhs in the preceding quarter.
📅 Company Track Record
Zim Laboratories previously scheduled its Q4 & FY26 earnings call on May 20, 2026, following its Q4 FY26 results filing on May 13, 2026. This indicates a consistent reporting schedule for quarterly financial performance.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Zim Laboratories Ltd.'s consolidated net profit/loss for the quarter ended 30 June 2026?
Zim Laboratories Ltd. reported a consolidated net loss after tax of Rs. (401.70) lakhs for the quarter ended 30 June 2026.
What was Zim Laboratories Ltd.'s consolidated revenue from operations in Q1 FY27?
Consolidated revenue from operations for Zim Laboratories Ltd. was Rs. 9,417.85 lakhs for the quarter ended 30 June 2026.
How did Zim Laboratories Ltd.'s total expenses compare in Q1 FY27?
Total consolidated expenses for Zim Laboratories Ltd. were Rs. 10,074.38 lakhs for the quarter ended 30 June 2026.
What were the basic and diluted earnings per share for Zim Laboratories Ltd. in Q1 FY27?
Basic and Diluted Earnings Per Share (EPS) for Zim Laboratories Ltd. were Rs. (0.75) for the quarter ended 30 June 2026.
Questions based on this BSE filing only. For information purposes.
All BSE filings we have analysed for Zim Laboratories Ltd.
You've read one filing
There are 32,000 more, and one of them is about a company you own
Follow a company and we'll email you the moment it files
again - explained, not just forwarded. Free.
Follow companies and get filings by email
Save any filing to read later
Two full AI analyses every month, free
No card needed. Sign in with Google in two taps.
⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔖
Save filings you care about
Sign in free to save any filing and get notified when the same company files again.
🔖
Save This Filing
Sign in with Google to save this filing and get notified when this company files again. Free, takes 5 seconds.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.